Related Experiment Video
Updated: Apr 12, 2026

06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
4.9K
Progressive multifocal leukoencephalopathy associated with immune dysregulation.
Odunayo Yusuf1, Mai Elrayes2, Khuloud Elsabbagh2
1Internal Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
BMJ Case Reports
|April 10, 2026
Summary
Progressive multifocal leukoencephalopathy (PML) can occur in patients with subtle immune issues, not just severe immunosuppression. This case highlights the need for advanced immune testing beyond T-cell counts for diagnosis.
Area of Science:
- Neuroimmunology
- Viral Neurology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic demyelinating disease of the central nervous system.
- PML is caused by the John Cunningham (JC) virus, typically in severely immunocompromised individuals.
- Subtle immune dysregulation can also predispose individuals to PML.
Purpose of the Study:
- To report a case of PML in a patient with autoimmune hepatitis-primary biliary cholangitis overlap syndrome on low-dose corticosteroids.
- To highlight diagnostic challenges and the utility of extended immune profiling in atypical PML presentations.
Main Methods:
- Case report of a woman in her 40s with autoimmune hepatitis-primary biliary cholangitis.
- Clinical assessment, MRI, cerebrospinal fluid (CSF) analysis for JC viral DNA, and comprehensive immunophenotyping.
- Analysis included CD4+, CD8+, CD19+ T-cell and B-cell counts, and immunoglobulin levels.
Main Results:
- The patient presented with cerebellar symptoms and MRI findings consistent with PML.
- JC viral DNA was detected in CSF.
- Despite normal T-cell counts, immunophenotyping revealed significant B-cell lymphopenia, polyclonal hypergammaglobulinaemia, and elevated free light chains, indicating functional immunodeficiency.
Conclusions:
- PML diagnosis can be challenging in patients with seemingly preserved T-cell immunity.
- Extended immune profiling, including B-cell enumeration and immunoglobulin analysis, is valuable for atypical PML cases.
- Therapeutic decisions require balancing immune reconstitution with autoimmune disease management.

